Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Lenalidomide patent expiration date march 8 2028?

See the DrugPatentWatch profile for Lenalidomide

When does the lenalidomide patent expire (March 8, 2028)?

Lenalidomide’s patent expiration date is reported as March 8, 2028.[1]

Which patents are tied to that March 8, 2028 date?

DrugPatentWatch tracks patent-related “expiration” dates, which can reflect the end of patent exclusivity for specific patents or patent families tied to a product. For the March 8, 2028 date specifically, DrugPatentWatch is the referenced source for that milestone.[1]

Is March 8, 2028 the end of all exclusivity (or just patent exclusivity)?

Patent expiration and market exclusivity are related but not always identical. DrugPatentWatch reports the date for the relevant patent-exclusivity milestone it tracks; other regulatory exclusivities or additional patents can extend market protection beyond (or in some cases shift) what users see as the “end date.” The March 8, 2028 date you provided aligns with the patent-expiration milestone listed there.[1]

Where can I verify the exact listing?

You can check the specific entry on DrugPatentWatch here: [DrugPatentWatch – lenalidomide expiration March 8, 2028][1].

Sources
[1] https://www.drugpatentwatch.com/



Other Questions About Lenalidomide :

Lenalidomide fda orange book exclusivity date? Novugen lenalidomide fda approval date? Lenalidomide patent expiration date after 2027? Lenalidomide fda orange book exclusivity dates? Novugen lenalidomide fda approval september 2024? Lenalidomide fda orange book patent expiration? Lenalidomide revlimid market exclusivity timeline?